Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Vitara Biomedical, Inc.

Vitara Biomedical, Inc.

Stage unknownPhiladelphia, PAvitara.comBiotechnology
Facts
Year of incorporation
2019sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
2
Financing history
1 rounds
  1. Oct 11, 2024
    Form D equity offering · $10.0M (form d sold) · 9 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Vitara Biomedical, Inc. filed Form D: $9,999,840 sold of $49,999,190, Biotechnology”
Investors on record
2 edges
People
1 officers, 6 directors
Timeline
1
  1. Oct 28, 2024
    Vitara Biomedical, Inc. filed Form D: $9,999,840 sold of $49,999,190, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
17 observations
Every observation on this company